MolNFT v1 · #72438 · protein

Crystal structure of blac-E166A covalently bound with ampicillin

3N8L · Beta-lactamase: “Crystal structure of blac-E166A covalently bound with ampicillin”. X-ray diffraction, 2 ligands (AIX, PO4), 1 pocket (best druggability 0.44). MolNFT v1 #72438 on GenesisL1: 3D structure, binding sites and pockets…

PDB: 3N8L
Type: protein
Length: 265 residues
Chains: 1
Method: x-ray diffraction
Collection: MolNFT v1 / PDB
Contract: 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner: 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule: Beta-lactamase
EC: 3.5.2.6
UniProt: P0C5C1
Ligands: AIX, PO4
Pockets: 1 · best druggability 0.44

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 17% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	Beta-lactamase (EC 3.5.2.6)	protein	265	46% helix, 17% strand	P0C5C1

Ligands and binding sites

AIX · (2R,4S)-2-[(1R)-1-{[(2R)-2-amino-2-phenylacetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid · ligand · chains A
PO4 · Phosphate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	119	0.44	0.78	27	PO4, AIX

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

3N8L · Crystal Structure of BlaC-E166A covalently bound with Ampicillin · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt P0C5C1
Elsewhere: RCSB PDB 3N8L · PDBe 3N8L · UniProt P0C5C1

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.